VitaNova Life Sciences (VNOV) Other financing activities (2017 - 2023)
VitaNova Life Sciences (VNOV) posted Other financing activities of $17282.0 for Q3 2023, up 208.61% on a QoQ basis from $5600.0 in Q1 2019.
VitaNova Life Sciences (VNOV) Other financing activities (2017 - 2023) Analysis & Trends
VitaNova Life Sciences' Other financing activities history runs 4 years deep, the most recent figure standing at $17282.0 for Q3 2023.
- Quarterly Other financing activities changed N/A year-over-year to $17282.0 in Q3 2023, while the trailing twelve-month figure through Apr 2025 was $17282.0 (changed 0.0% YoY) and the FY2024 annual result came in at $957051.0, changed N/A from the prior year.
- Other financing activities was $17282.0 for Q3 2023 at VitaNova Life Sciences, up from $5600.0 in the prior quarter.
- Across five years, Other financing activities topped out at $17282.0 in Q3 2023 and bottomed at $5600.0 in Q1 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Mckesson | 105.15 Bn | 101.18 Bn | 4.04 Bn |
| 2 | Cencora | 60.58 Bn | 58.40 Bn | 3.59 Bn |
| 3 | Cardinal Health | 53.81 Bn | 49.87 Bn | 2.50 Bn |
| 4 | Henry Schein | 9.71 Bn | 9.57 Bn | 1.07 Bn |
| 5 | Akso Health | 3.28 Bn | 3.28 Bn | - |
| 6 | 111 | 651.73 Mn | 572.63 Mn | 23.58 Mn |
| 7 | Accendra Health | 248.02 Mn | -88.86 Mn | 278.03 Mn |
| 8 | Edap Tms | 230.14 Mn | 215.14 Mn | 8.15 Mn |
| 9 | VitaNova Life Sciences | 11.51 Mn | 11.01 Mn | 316,343.00 |
| 10 | Cosmos Health | 9.57 Mn | 7.41 Mn | 1.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2023 | 17,282.00 |
| Jul 31, 2023 | 17,282.00 |
| Jan 31, 2019 | 5,600.00 |
| Jan 31, 2019 | 5,600.00 |
| Oct 31, 2018 | -5,600.00 |
| Oct 31, 2018 | -5,600.00 |
| Oct 31, 2017 | -6,000.00 |
| Oct 31, 2017 | -6,000.00 |
| Jul 31, 2017 | 5,700.00 |
| Jul 31, 2017 | 5,700.00 |